Abstract
The role of prognostic variables in the treatment of hepatocellular carcinoma (HCC) by transarterial chemoembolisation (TACE) is controversial. To evaluate the survival of patients with HCC on cirrhosis treated with TACE and to analyse the prognostic factors affecting survival. From 1996 to 2006, 580 consecutive patients with HCC in cirrhosis were observed. Of these 194 patients underwent TACE. The primary end-point was survival. Independent predictors of survival were identified using the Cox model. The cumulative 1-year, 3-year, and 5-year survival rates were 96%, 60%, and 41%, respectively. The multivariate analysis showed significant reduction of survival among patients with serum bilirubin values >2mg/dl compared to patients with values <2mg/dl (Hazard ratio 3.84; CI 95% 1.70-8.66; p-value=0.001). Multivariate analysis performed in the group of patients treated with TACE alone showed that elevated serum bilirubin (Hazard ratio 2.96; CI 95% 1.20-7.3; p-value 0.02) and incomplete tumour response (Hazard ratio 2.88; CI 95% 1.18-7.05; p-value 0.02) are correlated with a worse outcome. TACE was well tolerated and overall survival rate was 41% after 5 years. Complete tumour response and serum bilirubin <2mg/dl were identified as...Continue Reading
References
Nov 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E Christensen
Jul 1, 1993·Radiology·O MatsuiK Kogayashi
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·D M ParkinP Pisani
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chung-Mau LoJohn Wong
Jun 7, 2002·Lancet·Josep M LlovetUNKNOWN Barcelona Liver Cancer Group
Jul 2, 2002·Radiology·Calogero CammàMario Cottone
Jan 24, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Josep M Llovet, Jordi Bruix
Nov 27, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Margarita SalaUNKNOWN Barcelona Clínic Liver Cancer Group
Jul 13, 2005·Gut·S-M LinY-C Chen
Oct 20, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Maurizio BiselliMauro Bernardi
Oct 27, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN Practice Guidelines Committee, American Association for the Study of Liver Diseases
Nov 16, 2005·Transplantation·Andreas Lubienski
Jan 4, 2006·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·J DumortierP-J Valette
Aug 8, 2006·Gastroenterology·Kenichi TakayasuUNKNOWN Liver Cancer Study Group of Japan
Jul 20, 2007·Alimentary Pharmacology & Therapeutics·H ShenP Kwo
Nov 21, 2007·World Journal of Gastroenterology : WJG·Roberto MiragliaBruno Gridelli
Nov 11, 2008·Scandinavian Journal of Gastroenterology·Jeong Han KimKwan Soo Byun
Apr 17, 2009·World Journal of Gastroenterology : WJG·Rodolfo SaccoAlfonso Capria
Citations
Jan 8, 2013·Medical Oncology·Ji-Wen Cheng, Yi Lv
May 16, 2013·World Journal of Gastroenterology : WJG·Matan J CohenOren Shibolet
Jun 27, 2013·World Journal of Gastroenterology : WJG·Ke-Tong WuChuan-Xing Li
Apr 26, 2013·Radiology·Susanne BonekampIhab R Kamel
Feb 5, 2013·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Jon C HenryCarl R Schmidt
Feb 2, 2013·Journal of Vascular and Interventional Radiology : JVIR·Sanjeeva P KalvaAndrew X Zhu
Feb 7, 2013·Journal of Vascular and Interventional Radiology : JVIR·Marty T SellersSteven J Citron
May 14, 2011·Alimentary Pharmacology & Therapeutics·G CabibboC Cammà
Apr 24, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Yoshifumi SaitoKoichi Tokuuye
Feb 12, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Matan J CohenOren Shibolet
Aug 10, 2012·Clinical Drug Investigation·Osamu Matsui
Feb 9, 2017·PloS One·Hasmukh J Prajapati, Hyun S Kim
Jan 18, 2020·Diagnostic and Interventional Imaging·S YoungJ Golzarian